Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
g and acquisition program designed to identify and acquire additional ... KERYX CONTACT: Lauren Fischer Director - In... ... ... ...
Date:1/13/2009
g and acquisition program designed to identify and acquire additional drug candidates. Keryx is headquartered in New York City.
KERYX CONTACT:
Lauren Fischer
Director - Investor Relations
Keryx Biopharmaceuticals, Inc.
Tel: 212.531.5965
E-mail: lfischer@keryx.com
'/>"/>SOURCE Keryx Biopharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period2.
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT3.
Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference4.
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results5.
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT6.
Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference7.
Keryx Biopharmaceuticals Receives Nasdaq Notification8.
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan9.
Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference10.
Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint11.
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results